Scar Revision in the Office Setting

  • Neel S. Joshi
  • Zulara N. Wahla
  • Charles L. Castiglione


Scar revision is based on the body’s regenerative capacity. This chapter presents both surgical and non-surgical modalities for the management of facial scars in the outpatient, office setting.


Scars Keloids 


  1. 1.
    Barbul A, Efron DT, Kavalukas SL. Wound healing. In: Brunicardi FC, Andersen DK, Billiar TR, et al., editors. Schwartz’s principles of surgery. 10th ed. New York, NY: McGraw-Hill Education; 2015. p. 241–73.Google Scholar
  2. 2.
    Stedman’s medical dictionary for the health professions and nursing. Illustrated 7th ed. Lippincott Williams & Wilkins; 2011.Google Scholar
  3. 3.
    Brown BC, McKenna SP, Siddhi K, McGrouther DA, Bayat A. The hidden cost of skin scars: quality of life after skin scarring. J Plast Reconstr Aesthet Surg. 2008;61(9):1049–58. Scholar
  4. 4.
    Kwok T, Rao J. A practical approach to classification and treatment of scars. Skin Ther Lett Family Pract. 2011;7(6)Google Scholar
  5. 5.
    More than $16 billion spent on Cosmetic Plastic Surgery: American Society of Plastic Surgeons Releases Report Showing National Average of Cosmetic Surgical Fees in 2016. American Society of Plastic Surgeons News: Press Releases; April 12, 2017.Google Scholar
  6. 6.
    Thomas Hess C. Checklist for factors affecting wound healing. Adv Skin Wound Care. 2011;24(4):192. Scholar
  7. 7.
    Han J, Jin W, Ho NA, et al. Decursin and decursinol angelate improve wound healing by upregulating transcription of genes encoding extracellular matrix remodeling proteins, inflammatory cytokines, and growth factors in human keratinocytes. Biochem Biophys Res Commun. 2018;499(4):979–84. Scholar
  8. 8.
    American Society of Plastic Surgeons. 2016 Plastic Surgery Statistics | Average Surgeon Fees; 2016.Google Scholar
  9. 9.
    Eshun K, He Q. Aloe Vera: a valuable ingredient for the food, pharmaceutical and cosmetic industries—a review. Crit Rev Food Sci Nutr. 2004;44(2):91–6. Scholar
  10. 10.
    Spoerke DG, Ekins BR. Aloe Vera—fact or quackery. Vet Hum Toxicol. 1980;22:418–24.PubMedGoogle Scholar
  11. 11.
    Meadows TP. Aloe as a humectant in new skin preparations. Cosmet Toilet. 1980;95(11):51–6.Google Scholar
  12. 12.
    Dat AD, Poon F, Pham KBT, Doust J. Aloe vera for treating acute and chronic wounds. Cochrane Database Syst Rev. 2012;2
  13. 13.
    Maenthaisong R, Chaiyakunapruk N, Niruntraporn S, Kongkaew C. The efficacy of aloe vera used for burn wound healing: a systematic review. Burns. 2007;33(6):713–8. Scholar
  14. 14.
    Ehrlich HP, Tarver H, Hunt TK. Inhibitory effects of vitamin E on collagen synthesis and wound repair. Ann Surg. 1972;175(2):235–40.CrossRefGoogle Scholar
  15. 15.
    Jenkins M, Alexander JW, MacMillan BG, Waymack JP, Kopcha R. Failure of topical steroids and vitamin E to reduce postoperative scar formation following reconstructive surgery. J Burn Care Rehabil. 1986;7(4):309–12. Scholar
  16. 16.
    Khoo TL, Halim AS, Zakaria Z, Mat Saad AZ, Wu LY, Lau HY. A prospective, randomised, double-blinded trial to study the efficacy of topical tocotrienol in the prevention of hypertrophic scars. J Plast Reconstr Aesthet Surg. 2011;64(6):e137–45. Scholar
  17. 17.
    Baumann LS, Spencer J. The effects of topical vitamin E on the cosmetic appearance of scars. Dermatol Surg. 1999;25(4):311–5. Scholar
  18. 18.
    Palmieri B, Gozzi G, Palmieri G. Vitamin E added silicone gel sheets for treatment of hypertrophic scars and keloids. Int J Dermatol. 1995;34(7):506–9. Scholar
  19. 19.
    Shin TM, Bordeaux JS. The role of massage in scar management: a literature review. Dermatol Surg. 2012;38(3):414–23. Scholar
  20. 20.
    Kaada B, Torsteinbø O. Increase of plasma beta-endorphins in connective tissue massage. Gen Pharmacol Vasc S. 1989;20(4):487–9.CrossRefGoogle Scholar
  21. 21.
    Saulis AS, Mogford JH, Mustoe TA. Effect of mederma on hypertrophic scarring in the rabbit ear model. Plast Reconstr Surg. 2002;110(1):177–83.CrossRefGoogle Scholar
  22. 22.
    Cho JW, Cho SY, Lee SR, Lee KS. Onion extract and quercetin induce matrix metalloproteinase-1 in vitro and in vivo. Int J Mol Med. 2010;25(3):347–52. Scholar
  23. 23.
    Draelos ZD. The ability of onion extract gel to improve the cosmetic appearance of postsurgical scars. J Cosmet Dermatol. 2008;7(2):101–4. Scholar
  24. 24.
    Draelos ZD, Baumann L, Fleischer AB, Plaum S, Avakian EV, Hardas B. A new proprietary onion extract gel improves the appearance of new scars: a randomized, controlled, blinded-investigator study. J Clin Aesthet Dermatol. 2012;5(6):18–24.PubMedPubMedCentralGoogle Scholar
  25. 25.
    Chung VQ, Kelley L, Marra D, Jiang SB. Onion extract gel versus petrolatum emollient on new surgical scars: a prospective double-blinded study. Dermatol Surg. 2006;32(2):193–7. Scholar
  26. 26.
    Perkins K, Davey RB, Wallis KA. Silicone gel: a new treatment for burn scars and contractures. Burns. 1983;9(3):201–4. Scholar
  27. 27.
    O’Brien L, Jones DJ. Silicone gel sheeting for preventing and treating hypertrophic and keloid scars. Cochrane Database Syst Rev. 2013;9
  28. 28.
    Wei Y, Wang Y, Zhang M, et al. The application of 3D-printed transparent facemask for facial scar management and its biomechanical rationale. Burns. 2018;44(2):453–61. Scholar
  29. 29.
    Berman B, Harrison-Balestra C, Perez OA, Viera M, Villa A, Zell D, Ramirez C. Treatment of keloid scars post-shave excision with imiquimod 5% cream: a prospective, double-blind, placebo-controlled pilot study. J Drugs Dermatol. 2009;8(5):455–8.PubMedGoogle Scholar
  30. 30.
    Patel PJ, Skinner RB. Experience with keloids after excision and application of 5% imiquimod cream. Dermatol Surg. 2006;32(3):462. Scholar
  31. 31.
    Martin-Garcia RF, Busquets AC. Postsurgical Use of Imiquimod 5% Cream in the Prevention of earlobe keloid recurrences: results of an open-label, pilot study. Am Soc Dermatologic Surg. 2005;31(11):1394–8.Google Scholar
  32. 32.
    Stashower ME. Successful treatment of earlobe keloids with imiquimod after tangential shave excision. Dermatol Surg. 2006;32(3):380–6. Scholar
  33. 33.
    Humphrey CD, Thomas JR. Improving scars with minimally invasive and topical treatment. Oper Tech Otolaryngol. 2011;22(1):94–100. Scholar
  34. 34.
    Niessen FB, Spauwen PHM, Schalkwijk J, Kon M. On the nature of hypertrophic scars and keloids: a review. Plast Reconstr Surg. 1999;104(5):1435–58.CrossRefGoogle Scholar
  35. 35.
    Chowdri NA, Mattoo MMA, Darzi MA. Keloids and hypertrophic scars: results with intra-operative and serial postoperative corticosteroid injection therapy. Aust N Z J Surg. 1999;69(9):655–9. Scholar
  36. 36.
    McCoy BJ, Diegelmann RF, Cohen IK. In vitro inhibition of cell growth, collagen synthesis, and prolyl hydroxylase activity by triamcinolone acetonide. Proc Soc Exp Biol Med. 1980;163(2):216–22.CrossRefGoogle Scholar
  37. 37.
    Khansa I, Harrison B, Janis JE. Evidence-based scar management: how to improve results with technique and technology. Plast Reconstr Surg. 2016;138(3):165S–78S. Scholar
  38. 38.
    Atiyeh BS. Nonsurgical management of hypertrophic scars: evidence-based therapies, standard practices, and emerging methods. Aesthetic Plast Surg. 2007;31(5):468–92. Scholar
  39. 39.
    Longley DB, Harkin DP, Johnston PG. 5-Fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer. 2003;3(5):330–8. Scholar
  40. 40.
    Gupta S, Kalra A. Efficacy and safety of intralesional 5-fluorouracil in the treatment of keloids. Dermatology. 2002;204(2):130–2. Scholar
  41. 41.
    Kontochristopoulos G, Stefanaki C, Panagiotopoulos A, et al. Intralesional 5-fluorouracil in the treatment of keloids: an open clinical and histopathologic study. J Am Acad Dermatol. 2005;52(3):474–9. Scholar
  42. 42.
    Payapvipapong K, Niumpradit N, Piriyanand C, Buranaphalin S, Nakakes A. The treatment of keloids and hypertrophic scars with intralesional bleomycin in skin of color. J Cosmet Dermatol. 2015;14(1):83–90. Scholar
  43. 43.
    Har-Shai Y, Sabo E, Rohde E, Hyams M, Assaf C, Zouboulis CC. Intralesional cryosurgery enhances the involution of recalcitrant auricular keloids: a new clinical approach supported by experimental studies. Wound Repair Regen. 2006;14:18–27. Scholar
  44. 44.
    Zouboulis CC, Rosenberger AD, Forster T, Beller G, Kratzsch M, Felsenberg D. Modification of a device and its application for intralesional cryosurgery of old recalcitrant keloids. Arch Dermatol. 2004;140(10):1293–4. Scholar
  45. 45.
    Namazi MR, Fallahzadeh MK, Schwartz RA. Strategies for prevention of scars: what can we learn from fetal skin? Int J Dermatol. 2011;50(1):85–93. Scholar
  46. 46.
    Coleman SR. Structural fat grafting: more than a permanent filler. Plast Reconstr Surg. 2006;118(3 Suppl):108–20. Scholar
  47. 47.
    Rigotti G, Marchi A, Galiè M, et al. Clinical treatment of radiotherapy tissue damage by lipoaspirate transplant: a healing process mediated by adipose-derived adult stem cells. Plast Reconstr Surg. 2007;119(5):1409–22. Scholar
  48. 48.
    Kim M, Kim I, Lee SK, Bang SI, Lim SY. Clinical trial of autologous differentiated adipocytes from stem cells derived from human adipose tissue. Dermatol Surg. 2011;37(6):750–9. Scholar
  49. 49.
    Klinger M, Marazzi M, Vigo D, Torre M. Fat injection for cases of severe burn outcomes: a new perspective of scar remodeling and reduction. Aesthetic Plast Surg. 2008;32(3):465–9. Scholar
  50. 50.
    Boxrud CA. Adipocyte-derived stem cells for the face. Facial Plast Surg Clin North Am. 2012;20(2):231–4. Scholar
  51. 51.
    Castro DJ, Abergel RP, Meeker C, Dwyer RM, Lesavoy MA, Uitto J. Effects of the Nd:YAG laser on DNA synthesis and collagen production in human skin fibroblast cultures. Ann Plast Surg. 1983;11(3):214–22. Scholar
  52. 52.
    Sobanko JF, Alster TS. Laser treatment for improvement and minimization of facial scars. Facial Plast Surg Clin North Am. 2011;19(3):527–42. Scholar
  53. 53.
    Alster T, Zaulyanov-Scanlon L. Laser scar revision: a review. Dermatol Surg. 2007;33(2):131–40. Scholar
  54. 54.
    Kuo YR, Jeng SF, Wang FS, et al. Flashlamp pulsed dye laser (PDL) suppression of keloid proliferation through down-regulation of TGF-β1 expression and extracellular matrix expression. Lasers Surg Med. 2004;34(2):104–8. Scholar
  55. 55.
    Reiken SR, Wolfort SF, Berthiaume F, Compton C, Tompkins RG, Yarmush ML. Control of hypertrophic scar growth using selective photothermolysis. Lasers Surg Med. 1997;21(1):7–12.<7::AID-LSM2>3.0.CO;2-U.CrossRefPubMedGoogle Scholar
  56. 56.
    Fitzpatrick RE, Rostan EF, Marchell N. Collagen tightening induced by carbon dioxide laser versus erbium: YAG laser. Lasers Surg Med. 2000;27(5):395–403.<395::AID-LSM1000>3.0.CO;2-4.CrossRefPubMedGoogle Scholar
  57. 57.
    Mobley SR, Sjogren PP. Soft tissue trauma and scar revision. Facial Plast Surg Clin North Am. 2014;22(4):639–51. Scholar
  58. 58.
    Pierce GF, Mustoe TA, Lingelbach J, et al. Platelet-derived growth factor and transforming growth factor-β enhance tissue repair activities by unique mechanisms. J Cell Biol. 1989;109(1):429–40. Scholar
  59. 59.
    Min S, Yoon JY, Park SY, Moon J, Kwon HH, Suh DH. Combination of platelet rich plasma in fractional carbon dioxide laser treatment increased clinical efficacy of for acne scar by enhancement of collagen production and modulation of laser-induced inflammation. Lasers Surg Med. 2018;50(4):302–10. Scholar
  60. 60.
    Lee JW, Kim BJ, Kim MN, Mun SK. The efficacy of autologous platelet rich plasma combined with ablative carbon dioxide fractional resurfacing for acne scars: a simultaneous split-face trial. Dermatol Surg. 2011;37(7):931–8. Scholar
  61. 61.
    Ibrahim MK, Ibrahim SM, Salem AM. Skin microneedling plus platelet-rich plasma versus skin microneedling alone in the treatment of atrophic post acne scars: a split face comparative study. J Dermatolog Treat. 2018;29(3):281–6. Scholar
  62. 62.
    Tehranian A, Esfehani-Mehr B, Pirjani R, Rezaei N, Sadat Heidary S, Sepidarkish M. Application of autologous platelet-rich plasma (PRP) on wound healing after caesarean section in high-risk patients. Iran Red Crescent Med J. 2016;18(7)
  63. 63.
    Weiss RA, Weiss MA, Beasley KL, Munavalli G. Autologous cultured fibroblast injection for facial contour deformities: a prospective, placebo-controlled, phase III clinical trial. Dermatol Surg. 2007;33(3):263–8. Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Neel S. Joshi
    • 1
  • Zulara N. Wahla
    • 1
  • Charles L. Castiglione
    • 2
  1. 1.Department of SurgeryUniversity of Connecticut School of MedicineFarmingtonUSA
  2. 2.Hartford Hospital, Connecticut Children’s Medical CenterHartfordUSA

Personalised recommendations